Studies Peptides Calculator

Pepdox aggregates peer-reviewed research from PubMed. This site is for informational purposes only.

Built by Thorne

Do no harm: managing nausea and vomiting in GLP-1 based obesity therapies. | Pepdox

Home
Search
PMID 41852477

Do no harm: managing nausea and vomiting in GLP-1 based obesity therapies.

Frontiers in endocrinology2026PMID: 41852477

View on PubMed DOI: 10.3389/fendo.2026.1788698

Semaglutide Tirzepatide

Authors

Alhazmi, Abdulhameed; le Roux, Carel W

Keywords

GLP 1nausea & vomitingobesitysemaglutideside effecttirzepatide